Hugh Smyth
Hugh Smyth
Professor, Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas
Verified email at mail.utexas.edu - Homepage
Title
Cited by
Cited by
Year
3D Printing technologies for drug delivery: a review
LK Prasad, H Smyth
Drug development and industrial pharmacy 42 (7), 1019-1031, 2016
2112016
The influence of formulation variables on the performance of alternative propellant-driven metered dose inhalers
HDC Smyth
Advanced drug delivery reviews 55 (7), 807-828, 2003
1822003
Physical characterization of component particles included in dry powder inhalers. I. Strategy review and static characteristics
AJ Hickey, HM Mansour, MJ Telko, Z Xu, HDC Smyth, T Mulder, ...
Journal of pharmaceutical sciences 96 (5), 1282-1301, 2007
1492007
Excipient development for pharmaceutical, biotechnology, and drug delivery systems
A Katdare, M Chaubal
CRC Press, 2006
1362006
Influence of size and surface roughness of large lactose carrier particles in dry powder inhaler formulations
MJ Donovan, HDC Smyth
International journal of pharmaceutics 402 (1-2), 1-9, 2010
1142010
Carriers in drug powder delivery
HDC Smyth, AJ Hickey
American Journal of Drug Delivery 3 (2), 117-132, 2005
1022005
Controlled release pulmonary administration of curcumin using swellable biocompatible microparticles
IM El-Sherbiny, HDC Smyth
Molecular pharmaceutics 9 (2), 269-280, 2012
962012
Physicochemical properties of mucus and their impact on transmucosal drug delivery
J Leal, HDC Smyth, D Ghosh
International journal of pharmaceutics 532 (1), 555-572, 2017
942017
Physical characterization of component particles included in dry powder inhalers. II. Dynamic characteristics
AJ Hickey, HM Mansour, MJ Telko, Z Xu, HDC Smyth, T Mulder, ...
Journal of pharmaceutical sciences 96 (5), 1302-1319, 2007
912007
Delivery and therapeutic applications of gene editing technologies ZFNs, TALENs, and CRISPR/Cas9
JS LaFountaine, K Fathe, HDC Smyth
International journal of pharmaceutics 494 (1), 180-194, 2015
892015
Biodegradable nano-micro carrier systems for sustained pulmonary drug delivery:(I) self-assembled nanoparticles encapsulated in respirable/swellable semi-IPN microspheres
IM El-Sherbiny, HDC Smyth
International journal of pharmaceutics 395 (1-2), 132-141, 2010
882010
Dry powder inhaler device influence on carrier particle performance
MJ Donovan, SH Kim, V Raman, HD Smyth
Journal of pharmaceutical sciences 101 (3), 1097-1107, 2012
872012
Disruption of the mucus barrier by topically applied exogenous particles
SL McGill, HDC Smyth
Molecular pharmaceutics 7 (6), 2280-2288, 2010
872010
Swellable microparticles as carriers for sustained pulmonary drug delivery
IM El‐Sherbiny, S McGill, HDC Smyth
Journal of pharmaceutical sciences 99 (5), 2343-2356, 2010
862010
Biodegradable pH-responsive alginate-poly (lactic-co-glycolic acid) nano/micro hydrogel matrices for oral delivery of silymarin
IM El-Sherbiny, M Abdel-Mogib, AAM Dawidar, A Elsayed, HDC Smyth
Carbohydrate polymers 83 (3), 1345-1354, 2011
812011
2001: An odyssey in inhaler formulation and design
TM Crowder, MD Louey, VV Sethuraman, HDC SMYTH, AJ Hickey
Pharmaceutical technology 25 (7), 99-113, 2001
772001
Poly (ethylene glycol)–carboxymethyl chitosan-based pH-responsive hydrogels: photo-induced synthesis, characterization, swelling, and in vitro evaluation as potential drug carriers
IM El-Sherbiny, HDC Smyth
Carbohydrate research 345 (14), 2004-2012, 2010
762010
Swellable particles for drug delivery
HD Smyth, MJ Donovan
US Patent 8,440,231, 2013
752013
Challenges and future prospects for the delivery of biologics: oral mucosal, pulmonary, and transdermal routes
JO Morales, KR Fathe, A Brunaugh, S Ferrati, S Li, M Montenegro-Nicolini, ...
The AAPS journal 19 (3), 652-668, 2017
732017
Formulation approaches to short interfering RNA and MicroRNA: challenges and implications
D Guzman-Villanueva, IM El-Sherbiny, D Herrera-Ruiz, AV Vlassov, ...
Journal of pharmaceutical sciences 101 (11), 4046-4066, 2012
732012
The system can't perform the operation now. Try again later.
Articles 1–20